DK381188A - 2-amino-5-hydroxy-4-pyrimidon-forbindelser og deres anvendelse til fremstilling af et laegemiddel til behandling af inflammation eller andre leukotrien-formidlede sygdomme samt farmaceutiske praeparater indeholdende forbindelserne - Google Patents

2-amino-5-hydroxy-4-pyrimidon-forbindelser og deres anvendelse til fremstilling af et laegemiddel til behandling af inflammation eller andre leukotrien-formidlede sygdomme samt farmaceutiske praeparater indeholdende forbindelserne

Info

Publication number
DK381188A
DK381188A DK381188A DK381188A DK381188A DK 381188 A DK381188 A DK 381188A DK 381188 A DK381188 A DK 381188A DK 381188 A DK381188 A DK 381188A DK 381188 A DK381188 A DK 381188A
Authority
DK
Denmark
Prior art keywords
substituted
phenylalkyl
phenyl
alkyl
compounds
Prior art date
Application number
DK381188A
Other languages
English (en)
Other versions
DK381188D0 (da
Inventor
Frederik Judson Walker
John Lawrende Lamattina
Brian Thomas O'neill
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK381188D0 publication Critical patent/DK381188D0/da
Publication of DK381188A publication Critical patent/DK381188A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK381188A 1987-07-09 1988-07-08 2-amino-5-hydroxy-4-pyrimidon-forbindelser og deres anvendelse til fremstilling af et laegemiddel til behandling af inflammation eller andre leukotrien-formidlede sygdomme samt farmaceutiske praeparater indeholdende forbindelserne DK381188A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/001608 WO1989000423A1 (en) 1987-07-09 1987-07-09 2-amino-5-hydroxy-4-pyrimidones

Publications (2)

Publication Number Publication Date
DK381188D0 DK381188D0 (da) 1988-07-08
DK381188A true DK381188A (da) 1989-02-21

Family

ID=22202454

Family Applications (1)

Application Number Title Priority Date Filing Date
DK381188A DK381188A (da) 1987-07-09 1988-07-08 2-amino-5-hydroxy-4-pyrimidon-forbindelser og deres anvendelse til fremstilling af et laegemiddel til behandling af inflammation eller andre leukotrien-formidlede sygdomme samt farmaceutiske praeparater indeholdende forbindelserne

Country Status (12)

Country Link
EP (1) EP0303348B1 (da)
JP (1) JPH0629264B2 (da)
AT (1) ATE71370T1 (da)
CA (1) CA1310642C (da)
DE (1) DE3867563D1 (da)
DK (1) DK381188A (da)
ES (1) ES2037833T3 (da)
FI (1) FI883285A (da)
GR (1) GR3003908T3 (da)
IE (1) IE60210B1 (da)
PT (1) PT87944B (da)
WO (1) WO1989000423A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
WO2013066729A1 (en) * 2011-10-31 2013-05-10 Merck Sharp & Dohme Corp. Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
UA111861C2 (uk) 2011-11-15 2016-06-24 Такеда Фармасьютікал Компані Лімітед Ароматична гетероциклічна сполука дигідрокси
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB756189A (en) 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
US4153793A (en) * 1973-05-03 1979-05-08 Smith Kline & French Laboratories Limited Imidazo alkylamino pyrimidones
IN153791B (da) * 1979-03-10 1984-08-18 Soc D Etudes Prod Chimique
FR2503162A1 (fr) 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
GB8421427D0 (en) 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
DE3436380A1 (de) * 1984-10-04 1986-04-10 Bayer Ag, 5090 Leverkusen Selektiv-fungizide mittel auf pyrimidin-derivat-basis
JPS61205260A (ja) * 1985-03-08 1986-09-11 Zeria Shinyaku Kogyo Kk 新規な２−置換アミノ−６−（２−メトキシフエニ−ル）−４（３ｈ）−ピリミドン誘導体及びその製造法

Also Published As

Publication number Publication date
IE60210B1 (en) 1994-06-15
PT87944B (pt) 1995-03-01
DE3867563D1 (en) 1992-02-20
PT87944A (pt) 1989-06-30
CA1310642C (en) 1992-11-24
EP0303348B1 (en) 1992-01-08
IE882107L (en) 1989-01-09
ATE71370T1 (de) 1992-01-15
JPH0629264B2 (ja) 1994-04-20
JPS6429367A (en) 1989-01-31
EP0303348A1 (en) 1989-02-15
ES2037833T3 (es) 1993-07-01
FI883285A (fi) 1989-01-10
GR3003908T3 (da) 1993-03-16
DK381188D0 (da) 1988-07-08
WO1989000423A1 (en) 1989-01-26
FI883285A0 (fi) 1988-07-08

Similar Documents

Publication Publication Date Title
DK586588D0 (da) Terapeutiske heterocycliske forbindelser
DK160877C (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
DE3888756D1 (de) Carbamoylpyrrolidonderivate, ihre Verwendung und Herstellung.
DE3774795D1 (de) Phenoxyessigsaeure-verbindungen, ihre herstellung, pharmazeutische zusammensetzungen und deren verwendung.
DK0615549T3 (da) Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
NL930057I1 (nl) Aromatische verbindingen
DE3177205D1 (de) Industrielle verbindungen anwendbar als zwischenprodukte in der herstellung von in stellung 2 substituierten 4-hydroxy 3-quinolincarboxamid-derivaten und die herstellung von diesen zwischenprodukten.
SE8802412D0 (sv) Thiourea derivatives
DK381188A (da) 2-amino-5-hydroxy-4-pyrimidon-forbindelser og deres anvendelse til fremstilling af et laegemiddel til behandling af inflammation eller andre leukotrien-formidlede sygdomme samt farmaceutiske praeparater indeholdende forbindelserne
ES2099180T3 (es) Derivados del benzopirano y procedimientos para su preparacion.
DK0485219T3 (da) Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser
DK283189A (da) Phenothiazinderivater, deres fremstilling og farmaceutiske praeparater deraf
DE3884878D1 (de) Uricosuretische Zusammensetzung.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment